02.06.2015 Views

2005 SAGES Abstracts

2005 SAGES Abstracts

2005 SAGES Abstracts

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

POSTER ABSTRACTS<br />

Carvalho PhD, Debora S Carvalho,Gildo O Passos Jr,Frederico<br />

P Santos,Gilvan Loureiro MD,Carlos H Ramos MD,Frederico W<br />

Silva MD, Clínica Cirúrgica Videolaparoscópica Gustavo<br />

Carvalho, UPE - Universidade de Pernambuco, Recife - BRAZIL<br />

BACKGROUND: Barrett´s Esophagus (BE) is a complication of<br />

Gastro-esophageal Reflux Disease (GERD) and can be a premalignant<br />

condition. Anti-reflux laparascopic surgeries (ARLS)<br />

significantly correct physiological and anatomical abnormalities<br />

in patients with GERD; nevertheless, there is no consensus<br />

with respect to its effectiveness in preventing malignant transformation<br />

in patients with BE. The impact of ARLS on those<br />

suffering from BE and in particular its effect not only on the<br />

regression of metaplasia but also on the progression of metaplasia<br />

and dysplasia towards adenocarcinoma, remain barely<br />

transparent.<br />

OBJECTIVE: To analyze clinical, endoscopic and histopathological<br />

results after ARLS in patients suffering from BE.<br />

PATIENTS & METHOD: In the period from January 2000 to<br />

June 2004, a group of 142 patients suffering from GERD<br />

underwent ARLS performed by the same surgeon. Among<br />

these, 42 patients (29,5%) suffered from BE. All the patients<br />

underwent Nissen fundoplication by laparascopic means.<br />

There were no conversions to open surgery. All patients were<br />

discharged within 24 hours. Post-operative follow-up using<br />

endoscopy and biopsy was carried out in all 42 patients with<br />

BE.<br />

RESULTS: After follow-up which varied from 3 to 40 months,<br />

symptomatic control was good in most patients: three patients<br />

developed recurrence of the symptoms and are making regular<br />

use of proton pump inhibitor, thus BE remains unaltered in<br />

these patients. Partial or complete regression of BE occurred<br />

in 25 patients with 14 of them not showing any further signs of<br />

BE in endoscopic or histopathological examination. And in 1<br />

patient who remained asymptomatic after surgery, the degree<br />

of dysplasia increased, which led to his undergoing endoscopic<br />

mucosectomy of the BE area. No patient presented adenocarcinoma<br />

after surgery. No-one died or suffered any significant<br />

complication as a result of surgery.<br />

CONCLUSIONS: Laparoscopic Nissen fundoplication is safe<br />

and effective in the symptomatological control of a significant<br />

number of patients with BE. Regression of BE occurred at a<br />

randomly high percentage level in patients operated despite<br />

the control of GERD attained by most patients.<br />

P012–Posters of Distinction<br />

NAUSEA AND GASTROESOPHAGEAL REFLUX DISEASE: IS<br />

SURGERY THE CAUSE OR THE CURE, Yashodhan S<br />

Khajanchee MD, Barbara Lockhart RN,Lee L Swanstrom MD,<br />

Department of MIS, Legacy Health System, Portland, OR<br />

Objective: Nausea is a common symptom in GERD patients<br />

referred for antireflux surgery (ARS). Postoperative nausea can<br />

lead to devastating complications and failure of the surgery.<br />

The aim of this study is to determine the incidence and patient<br />

characteristics of nausea as a presenting complaint and to<br />

document the effect of ARS on it.<br />

Methods: 671 patients undergoing ARS were selected from a<br />

prospective database of patients undergoing various<br />

esophageal surgeries at our institution. Exclusion criteria were:<br />

surgery before 1993 (early technique), Heller myotomy, < 6<br />

months follow-up, or failure to complete nausea portion of the<br />

symptom assessment tool. Symptoms were recorded on a<br />

scale of 0-4 with higher ordinal values representing greater<br />

frequency of symptoms. Logistic regression modeling was<br />

performed to identify factors most significant for persistent<br />

nausea following ARS. Comparisons were done using chisquare<br />

test or t-test as appropriate.<br />

Results: Overall 185 (27.2 %) patients had some nausea preoperatively<br />

(mean severity score 2.0 [±0.88]). Women, younger<br />

patients, and patients with other associated GI symptoms or<br />

PEH had significantly higher incidence of nausea (p < 0.05).<br />

After surgery 498 (74.2%) patients had some degree of nausea<br />

at early post-operative visit (median 3.5 weeks). At long-term<br />

follow-up (median 9 months) 149 (22.2%) patients experienced<br />

nausea (45 persistent nausea, 104 new onset nausea, overall<br />

mean severity score 1.75 [±0.82]). Odds of persistent nausea<br />

were higher among women (odds ratio [OR] 3.5), in patients<br />

undergoing Toupet repair (OR-6.5), Collis gastroplasty (OR 3.4),<br />

or redo ARS (OR 1.5), and in those having preoperative nausea<br />

(OR 1.14) or functional GI disorders (OR 1.17). However, none<br />

of the factors were found to be statistically significant.<br />

Conclusion: Nausea is a frequent presenting component of<br />

GERD. It can also be a devastating postoperative complication<br />

leading to failure. Our data shows that majority (75.6%) of<br />

patients with preoperative nausea are cured with fundoplication.<br />

However, there are a significant number of patients who<br />

develop new onset nausea after surgery. It is difficult to predict<br />

who will develop nausea after surgery, so surgeons should<br />

counsel all patients about this possibility.<br />

P013–Posters of Distinction<br />

LARYNGOPHARYNGEAL REFLUX CAN EXIST WITH NORMAL<br />

DISTAL ESOPHAGEAL ACID EXPOSURE, Rami E Lutfi MD,<br />

Alfonso Torquati MD,Nikhilesh Sekhar MD,William O Richards<br />

MD, Vanderbilt University<br />

Laryngopharyngeal reflux (LPR) has been detected in patients<br />

with gastroesophageal reflux disease (GERD). The prevalence<br />

of GERD in patients with LPR remains unknown.<br />

Aim: to determine if pathologic proximal esophageal reflux<br />

can exist without pathologic distal reflux.<br />

Methods: Database was reviewed for triple probe pH studies.<br />

Each included manometry and 24-hr pH study using 3 probes<br />

(distal, middle, located 5 and 15cm proximal to lower<br />

esophageal sphincter, LES, and extraesophageal located at<br />

2cm above the upper sphincter). Comparison was made using<br />

Student t test for continuous, and chi square for independent<br />

variables.<br />

Results: 113 triple probe studies were performed for different<br />

LPR symptoms (laryngitis, 31%; chronic cough, 19%; hoarseness,<br />

9%; vocal cord nodules, 11%; and subglottic stenosis,<br />

4%). Pathologic LPR was defined according to our previous<br />

study on healthy volunteers as >4 reflux episodes detected by<br />

the extraesophageal probe. 45 patients had pathologic LPR; of<br />

those, only 24 (53%) had abnormal distal acid exposure time<br />

(>4.1%) with elevated DeMeester score (¡Y22). The difference<br />

in incidence of abnormal distal acid exposure or DeMeester<br />

score was not statistically significant between patients with or<br />

without pathologic LPR. Mean DeMeester score and distal acid<br />

exposure time were both higher in LPR group, but the difference<br />

did not reach statistical significance (34+/-30 vs. 27+/-34,<br />

p=0.238, and 6.5+/-5.9% vs. 5.2+/-6.4, p=0.277, respectively).<br />

Using t test, LES pressure, contraction amplitudes, and peristalsis<br />

were compared between the same two groups (with or<br />

without LPR); no statistically significant difference was found.<br />

No correlation was found between the severity of LPR and<br />

GERD severity when Pearson Correlation test was run between<br />

the number of proximal reflux episodes and DeMeester score<br />

(r=0.073, p=0.443). Conclusion: Pathologic LPR can exist without<br />

pathologic distal acid exposure. To accurately diagnose<br />

LPR, a hypopharyngeal sensor must be used with the standard<br />

distal pH sensors located at 5, and 15 cm from the LES.<br />

P014–Posters of Distinction<br />

POUCH ENLARGEMENT AND BAND SLIPPAGE, TWO DIFFER-<br />

ENT ENTITIES, Frederico Moser MD, Santiago Horgan MD,M V<br />

Gorodner MD,C Galvani MD,M Baptista MD,A. Arnold MD,<br />

University of Illinois at Chicago<br />

Background: pouch enlargement (PE) and band slippage (BS)<br />

are the most common late complications of the laparoscopic<br />

adjustable gastric banding (LAGB). Often, confusion exists<br />

among surgeons regarding the denomination or even the<br />

treatment for these two different entities.<br />

Objectives: to establish the differences in clinical presentation,<br />

radiological features and management between PE and BS.<br />

Hypothesis: a) PE can be managed non operatively (band<br />

deflation); b) BS is an acute complication that requires surgical<br />

treatment; c) tailored adjustment allows earlier diagnosis of PE<br />

in asymptomatic patients.<br />

Methods: From 3/01 to 7/04, 470 patients underwent LAGB<br />

placement. Barium swallow was performed pre, postoperatively<br />

and during band adjustments (?tailored adjustment?). PE<br />

was defined as dilatation of the pouch; BS was considered<br />

when band and stomach were prolapsed. PE was divided in 4<br />

radiologic types. 1) PE, band 45?; 2) PE, covering the band,<br />

band 45?; 3) PE, band 0? and 4) PE, band < 0?.<br />

http://www.sages.org/<br />

<strong>SAGES</strong> <strong>2005</strong><br />

127

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!